Smallpox Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders
Conditions:   Dermatitis, Atopic;   Hay FeverIntervention:   Biological: IMVAMUNE (MVA-BN)Sponsors:   Bavarian Nordic;   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2005 Category: Research Source Type: clinical trials

Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Condition:   SmallpoxIntervention:   Biological: IMVAMUNE (MVA-BN)Sponsors:   Bavarian Nordic;   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2005 Category: Research Source Type: clinical trials

Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
Condition:   SmallpoxInterventions:   Biological: ACAM1000;   Biological: vaccinia virus (calf lymph) smallpox vaccine: DryvaxSponsors:   Sanofi;   Sanofi Pasteur, a Sanofi CompanyTerminated - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2003 Category: Research Source Type: clinical trials